Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
04/2004
04/14/2004EP1406911A1 6-[2-(phosphonomethoxy)alkoxy]pyrimidine derivatives having antiviral activity
04/14/2004EP1406910A1 Novel bisphosphonate derivatives, their preparation methods and uses
04/14/2004EP1406879A1 Novel chelating agents and conjugates thereof, their synthesis and use as diagnostic and therapeutic agents
04/14/2004EP1301522A4 Novel compounds and methods
04/14/2004EP1156054B1 Drugs containing phosphoric acid derivatives as the active ingredient
04/14/2004EP1105399B1 Carboxylated phosphatidic acid esters
04/14/2004EP0912565B1 Process for preparing imidazoquinolinamines
04/14/2004CN1489596A šŒ-substituted š�-aminoethyl phosphonates
04/14/2004CN1489595A Method for preparing š� phosphorus-contained nitroxide free radical
04/14/2004CN1488635A Novel method for preparing VC magnesium phosphate ester
04/14/2004CN1488634A Rare earth heteropolyacid salt anti SARS virus medicine and synthesizing method thereof
04/14/2004CN1145633C Hydroformylation using multidentate phosphite ligands
04/14/2004CN1145632C Complex compound of element of sub-group IV
04/14/2004CN1145625C Process for the production of tert-buty1 (E)-(6[2-[4-(4-fluorophenyl)-6-isopropyl-2[methyl(methyl sulfonyl)amino]pyrimidin5-yl](4R,65)-2,2-dimethyl[1,3]dioxan-4-yl]acetate ])
04/14/2004CN1145618C Cycloformate derivatives as progesterone receptor modulators
04/14/2004CN1145614C Irreversible inhibitors of tyrosine kinases, its pharmaceutical use and medicine composition thereof
04/14/2004CN1145489C Inositol polyphosphate derivatives and mthod of using same
04/13/2004US6720442 Preparation of phosphorus-containing compounds useful in the preparation of biphosphine ligands
04/13/2004US6720439 Synthesis of ruthenium-hydride complexes and preparation procedures of chiral alcohols and ketones
04/13/2004US6720323 Colchinol derivatives as angiogenesis inhibitors
04/13/2004US6720281 Chiral phosphorus ligands and the use thereof in the production of optically active products
04/13/2004US6720136 Solid phase quenching systems
04/13/2004CA2276747C Methods and devices for the reduction of small organic compounds from blood products
04/08/2004WO2004029064A1 (+)-trans-isomers of (1-phosphonomethoxy-2-alkylcyclopropyl) methyl nucleoside derivatives, process for the preparation of stereoisomers thereof, and use of antiviral agents thereof
04/08/2004WO2004029063A1 Method for the production of acylphosphine oxides
04/08/2004WO2004028689A2 Process for the hydroformylation of an ethylenically unsaturated compound using a bidentate diphosphine composition with a bridging group comprising sp2 hybridized carbon atoms bound to the phosphorous atoms
04/08/2004WO2004014926A3 Alkoxyamines originating from beta-phosphorylated nitroxides and use thereof in radical polymerisation
04/08/2004WO2004002994A3 Novel phosphonocarboxylic acid esters
04/08/2004WO2003100073A3 Method for producing phosphoric acid triesters
04/08/2004US20040068138 Use of tellurium in carbon-supported, noble metal-containing catalysts for liquid phase oxidation reactions
04/08/2004US20040068132 Compounds comprising phosphorus-containing metal complexes
04/08/2004US20040068131 Production of novel phosphane ligands and use in catalytical reactions
04/08/2004US20040068126 Such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation, isomerization, cyclopropanation, Diels-Alder reaction, etc.
04/08/2004US20040068111 Useful as anti-viral agents against DNA viruses, retroviruses and viruses involved in tumor formation
04/08/2004US20040067966 Adenosine receptor antagonists and methods of making and using the same
04/08/2004US20040067945 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
04/08/2004US20040067933 Prevent bile acid transportation; antilipemic agents; anticholesterol agents
04/08/2004US20040067924 Actinium-225 complexes and conjugates for targeted radiotherapy
04/08/2004US20040067872 Novel mono- and di-fluorinated benzothiepine compouds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake
04/08/2004US20040067200 Contrast agents in X-ray imaging, magnetic resonance imaging and radiopharmaceuticals
04/08/2004CA2499889A1 (+)-trans-isomers of (1-phosphonomethoxy-2-alkylcyclopropyl) methyl nucleoside derivatives, process for the preparation of stereoisomers thereof, and use of antiviral agents thereof
04/07/2004EP1405898A1 Lubricant composition
04/07/2004EP1405892A1 Red fluorescent material and composition containing the same
04/07/2004EP1405854A1 Lithium p-diarylphosphinobenzenesulfonates, process for preparation of the same and use thereof
04/07/2004EP1404696A1 Activators for oligonucleotide synthesis
04/07/2004EP1404643A2 Cleavable surfactants and methods of use thereof
04/07/2004EP1404330A1 Substituted 8-arylquinoline pde4 inhibitors
04/07/2004EP1372594A4 Water-in-stable kojic acid derivatives and method for preparing thereof, and whitening cosmetics composition containing the same
04/07/2004CN1487949A Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same
04/07/2004CN1487946A Flame-proofing agents
04/07/2004CN1486986A Prepn process of monoacyl phosphine oxide
04/07/2004CN1144808C Preparation method for low chloride stabilizer
04/07/2004CN1144807C Process for producing condensed phosphoric esters
04/07/2004CN1144793C Polar-substituted hydrocarbons
04/07/2004CN1144616C Double metal cyanide catalysts for producing polyether polyols
04/06/2004US6717016 Phosphine compound, transition metal complex containing the same phosphine compound as ligand and asymmetric synthesis catalyst containing the complex
04/06/2004US6717011 Chiral diazaphospholidine ligands
04/06/2004US6717007 Regiospecific synthesis of phosphonous acids
04/06/2004US6717005 Total acid number reduction
04/06/2004US6716994 Fluorescence based four color nucleic acid sequencing
04/06/2004US6716984 Contacting phosphine compound ofthe formula xpr1r2, wherein x is a halogen, with the solid support, resulting in the p in the phosphine attached indirectly or directly to solid support via a covalent bonds, and replacing r1 or r2 groups
04/06/2004US6716882 Highly packed polycationic ammonium, sulfonium and phosphonium lipids
04/06/2004US6716870 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
04/06/2004US6716833 Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
04/06/2004US6716828 Treatment or prevention of neural or cardiovascular tissue damage related to cerebral ischemia and reperfusion injury in an animal by administering poly(adp- ribose) polymerase (?parp?) inhibitors.
04/06/2004US6716825 Osteoporosis and other disorders of bone metabolisum, cancer, viral infections, and the like.
04/06/2004CA2223927C Detection of transmembrane potentials by optical methods
04/06/2004CA2146877C Sulphonyl amino carbonyl triazolinones
04/06/2004CA2067381C Treatment of hiv infections and compounds useful therein
04/02/2004CA2443883A1 Lubricant composition
04/01/2004WO2004027378A2 Luminescence-based methods and probes for measuring cytochrome p450 activity
04/01/2004WO2004026885A1 Process for the preparation of acid esters
04/01/2004WO2004026884A1 Carboxylic acid derivatives containing phosphorous groups and organically polymerisable groups
04/01/2004WO2004026844A1 Methods and compositions of novel triazine compounds
04/01/2004WO2004026804A1 Anthraquinone quencher dyes, their methods of preparation and use
04/01/2004WO2004026803A1 Method for producing dialdehydes and/or ethylenically unsaturated monoaldehydes by hydroformylating ethylenically unsaturated compounds
04/01/2004WO2004026454A2 Formation of enediynes by reductive coupling followed by alkyne metathesis
04/01/2004WO2004026315A1 Substituted ketophosphonate compounds having bone anabolic activity
04/01/2004WO2004026245A2 Substituted phosphonate compounds having bone anabolic activity
04/01/2004WO2004007508A3 Nitrile production from ethylenically unsaturated compounds
04/01/2004WO2004005478A3 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
04/01/2004WO2003103816A3 An aqueous dispersion containing pyrogenically prepared metal oxide particles and dispersants
04/01/2004WO2003099830A3 Cardiolipin compositions, methods of preparation and use
04/01/2004WO2003082218A3 Photosensitive adhesive composition
04/01/2004WO2003057012A8 S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer
04/01/2004WO2002076402A3 Fatty amine drug conjugates
04/01/2004WO2002074473A3 Method of producing tantalum and niobium alkoxides
04/01/2004US20040063996 Reacting hexahydrotriazine with triacyl phosphite
04/01/2004US20040063995 From sodium salt of iminodiacetic acid with phosphorus trichloride; then with formaldehyde
04/01/2004US20040063966 Catalytic hydrogenation processes
04/01/2004US20040063956 Hydrocyanation method for ethylenically unsaturated organic compounds
04/01/2004US20040063925 Amplification; polymerase chain reaction
04/01/2004US20040063916 Bactericides; antibiotics
04/01/2004US20040063707 Azaindole kinase inhibitors
04/01/2004US20040063671 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
04/01/2004US20040063668 Antiviral agent; hepatitis B; such as ((1-((6-amino-9H-purin-9-yl)methyl)cyclopropyl)oxy)methylphosphonic acid
04/01/2004US20040063574 Catalyst compounds with beta-diiminate anionic ligands and processes for polymerizing olefins
04/01/2004US20040063200 Biological component comprising artificial membrane
04/01/2004DE10244684A1 Verfahren zur Herstellung von Acylphosphinoxiden Process for the preparation of acylphosphine oxides
04/01/2004CA2499964A1 Methods and compositions of novel triazine compounds